JAK Inhibitors   

Questions discussed in this category



Are you less likely to prescribe it for patients with dyslipidemia or autoimmune disease?

Would the etiology of the thrombocytosis play a role in your decision-making?


Papers discussed in this category


Arthritis & rheumatology (Hoboken, N.J.), 2016-11

Annals of the rheumatic diseases, 2019-04

Journal for immunotherapy of cancer, 2022 Jan

Clinical rheumatology, 2020 Sep 28

Frontiers in immunology, 2022 Sep 15

Cancer cell, 2022 May 09

Annals of the rheumatic diseases, 2023 May 29

Arthritis & rheumatology (Hoboken, N.J.), 2017-03

Annals of the rheumatic diseases, 2019 Jul 30

N Engl J Med,

Autoimmunity reviews, 2023 Dec 20